{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:08:22Z","timestamp":1793210902357,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","award":["F.6-1\/2010-Acad"],"award-info":[{"award-number":["F.6-1\/2010-Acad"]}],"id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006464","name":"Birla Institute of Technology and Science, Pilani","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.exer.2024.110098","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T06:17:20Z","timestamp":1726294640000},"page":"110098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Organic cation transporter 1 in the lacrimal gland facilitates the entry of systemic drugs causing ocular surface toxicity"],"prefix":"10.1016","volume":"248","author":[{"given":"Manisha","family":"Malani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumurthy","family":"Velpandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7864-6053","authenticated-orcid":false,"given":"Jayabalan","family":"Nirmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.exer.2024.110098_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ceyr.18.2.91.5381","article-title":"Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs","volume":"18","author":"Acheampong","year":"1999","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2024.110098_bib2","first-page":"18","article-title":"[Ocular manifestation in amiodarone toxicity--case report]","volume":"49","author":"Bratulescu","year":"2005","journal-title":"Oftalmologia"},{"key":"10.1016\/j.exer.2024.110098_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4615-2417-5_5","article-title":"Carbonic anhydrase and acinar cell heterogeneity in rat and rabbit lacrimal glands","author":"Bromberg","year":"1994","journal-title":"Lacrimal Gland, Tear Film, and Dry Eye Syndromes: Basic Science and Clinical Relevance"},{"issue":"3","key":"10.1016\/j.exer.2024.110098_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000055537","article-title":"Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes","volume":"31","author":"Burgalassi","year":"1999","journal-title":"Ophthalmic Res."},{"issue":"4","key":"10.1016\/j.exer.2024.110098_bib5","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The Lancet global health Commission on global eye health: vision beyond 2020","volume":"9","author":"Burton","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.exer.2024.110098_bib6","article-title":"Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy","author":"Castells","year":"2002","journal-title":"Optometry: J. Am. Optom. Assoc."},{"issue":"10","key":"10.1016\/j.exer.2024.110098_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jps.2600801002","article-title":"Systemic morphine pharmacokinetics after ocular administration","volume":"80","author":"Chast","year":"1991","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.exer.2024.110098_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OPTO.S355091","article-title":"A review of ocular complications associated with medications used for anxiety, depression, and stress","volume":"14","author":"Constable","year":"2022","journal-title":"Clin. Optom."},{"issue":"5","key":"10.1016\/j.exer.2024.110098_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0039-6257(79)90158-9","article-title":"The blood-ocular barriers","volume":"23","author":"Cunha-Vaz","year":"1979","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2024.110098_bib10","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1167\/iovs.09-4687","article-title":"Duct system of the rabbit lacrimal gland: structural characteristics and role in lacrimal secretion","volume":"51","author":"Ding","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2024.110098_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/exer.1994.1087","article-title":"Immunohistochemical evidence for the presence of vasopressin in the rat harderian gland, retina and lacrimal gland","volume":"59","author":"Djeridane","year":"1994","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2024.110098_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of organic cation transporter 2 (OCT2) to cisplatin\u2010induced nephrotoxicity","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.exer.2024.110098_bib13","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1167\/iovs.07-1528","article-title":"Expression and localization of carnitine\/organic cation transporter OCTN1 and OCTN2 in ocular epithelium","volume":"49","author":"Garrett","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.110098_bib14","series-title":"Laboratory Procedures","article-title":"Extraction and purification of total RNA using trizol or tri reagent","author":"Gottshall","year":"2008"},{"issue":"18","key":"10.1016\/j.exer.2024.110098_bib15","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1021\/jm400966v","article-title":"Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2","volume":"56","author":"Hendrickx","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2024.110098_bib16","article-title":"Establishment of a severe dry eye model using complete dacryoadenectomy in rabbits","volume":"155","author":"Honkanen","year":"2020","journal-title":"JoVE"},{"key":"10.1016\/j.exer.2024.110098_bib17","article-title":"CARRIER-MEDIATED transport of doxorubicin in cardiomyocytes","volume":"103","author":"Huang","year":"2018","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.exer.2024.110098_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/17425255.2020.1755253","article-title":"Role of SLC transporters in toxicity induced by anticancer drugs","volume":"16","author":"Huang","year":"2020","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.exer.2024.110098_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.aanat.2022.151991","article-title":"Immunohistochemical detection of urea transporter-A in the tear-producing part of the lacrimal system","volume":"244","author":"J\u00e4ger","year":"2022","journal-title":"Annals of Anatomy - Anatomischer Anzeiger"},{"key":"10.1016\/j.exer.2024.110098_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11095-004-1193-3","article-title":"Metformin transport by renal basolateral organic cation transporter hOCT2","volume":"22","author":"Kimura","year":"2005","journal-title":"Pharmaceut. Res."},{"issue":"7","key":"10.1016\/j.exer.2024.110098_bib21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.exer.2024.110098_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharmaceut. Res."},{"issue":"3","key":"10.1016\/j.exer.2024.110098_bib23","doi-asserted-by":"crossref","first-page":"R793","DOI":"10.1152\/ajpregu.00087.2005","article-title":"Carnitine\/xenobiotics transporters in the human mammary gland epithelia, MCF12A","volume":"290","author":"Kwok","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2","key":"10.1016\/j.exer.2024.110098_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00002018-200831020-00003","article-title":"Drug-induced ocular disorders","volume":"31","author":"Li","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.exer.2024.110098_bib25","series-title":"Ocular Side Effects of Systemically Administered Chemotherapy","author":"Liu","year":"2018"},{"issue":"9","key":"10.1016\/j.exer.2024.110098_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.exer.2024.110098_bib27","first-page":"1","article-title":"Interaction of systemic drugs causing ocular toxicity with organic cation transporter: an artificial intelligence prediction","author":"Malani","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.exer.2024.110098_bib28","article-title":"Retinal pathophysiological evaluation in a rat model","volume":"183","author":"Malani","year":"2022","journal-title":"JoVE"},{"issue":"2","key":"10.1016\/j.exer.2024.110098_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/112067219300300206","article-title":"Dopamine and its metabolites in human tears","volume":"3","author":"Martin","year":"1993","journal-title":"Eur. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2024.110098_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/112067219400400305","article-title":"Serotonin in human tears","volume":"4","author":"Martin","year":"1994","journal-title":"Eur. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2024.110098_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00055735-199912000-00012","article-title":"Ocular toxicity associated with systemic drug therapy","volume":"10","author":"Moorthy","year":"1999","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2024.110098_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/ICU.0000000000000860","article-title":"Effects of systemic targeted immunosuppressive therapy on ocular surface","volume":"33","author":"Mukhtar","year":"2022","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2024.110098_bib33","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"M\u00fcller","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.exer.2024.110098_bib34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1023\/A:1025032511040","article-title":"pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug\u2013drug interactions","volume":"20","author":"Neuhoff","year":"2003","journal-title":"Pharmaceut. Res."},{"issue":"10","key":"10.1016\/j.exer.2024.110098_bib35","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/eye.2013.146","article-title":"Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically","volume":"27","author":"Nirmal","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.exer.2024.110098_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2013.07.004","article-title":"Role of organic cation transporters in the ocular disposition of its intravenously injected substrate in rabbits: implications for ocular drug therapy","volume":"116","author":"Nirmal","year":"2013","journal-title":"Exp. Eye Res."},{"issue":"9\u201310","key":"10.1016\/j.exer.2024.110098_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jchromb.2011.01.019","article-title":"Development and validation of a highly sensitive LC\u2013MS\/MS method for organic cation transporter (OCT) substrate tetraethylammonium (TEA) in rabbits","volume":"879","author":"Nirmal","year":"2011","journal-title":"J. Chromatogr. B"},{"issue":"12","key":"10.1016\/j.exer.2024.110098_bib38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3109\/02713683.2012.715715","article-title":"Evaluation of the functional importance of organic cation transporters on the ocular disposition of its intravitreally injected substrate in rabbits","volume":"37","author":"Nirmal","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2024.110098_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01736-7","article-title":"Role of taurine transporter in the retinal uptake of vigabatrin","volume":"21","author":"Police","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.exer.2024.110098_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/ijd.IJD_353_18","article-title":"Ocular side effects of systemic drugs used in dermatology","volume":"64","author":"Prakash","year":"2019","journal-title":"Indian J. Dermatol."},{"issue":"11","key":"10.1016\/j.exer.2024.110098_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111664","article-title":"Atypical substrates of the organic cation transporter 1","volume":"12","author":"Redeker","year":"2022","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.exer.2024.110098_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/11533180-000000000-00000","article-title":"Ocular adverse effects of common psychotropic agents","volume":"24","author":"Richa","year":"2010","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.exer.2024.110098_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","article-title":"Ocular adverse effects associated with systemic medications","volume":"67","author":"Santaella","year":"2007","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.exer.2024.110098_bib44","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.4103\/ijo.IJO_3746_20","article-title":"Ethambutol toxicity: expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy","volume":"69","author":"Saxena","year":"2021","journal-title":"Indian J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2024.110098_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1542-0124(12)70222-7","article-title":"A lacrimal gland is a lacrimal gland, but rodent's and rabbit's are not human","volume":"8","author":"Schechter","year":"2010","journal-title":"Ocul. Surf."},{"issue":"11","key":"10.1016\/j.exer.2024.110098_bib46","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1080\/02713683.2021.1925698","article-title":"Evaluation of the presence and functional importance of nucleoside transporters in lacrimal gland for tear disposition of intravenously injected substrate in rabbits","volume":"46","author":"Sharma","year":"2021","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.exer.2024.110098_bib47","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1167\/iovs.05-0363","article-title":"Gene expression in rat lacrimal gland duct cells collected using laser capture microdissection: evidence for K+ secretion by duct cells","volume":"47","author":"Ubels","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.exer.2024.110098_bib48","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/00498250802334409","article-title":"Effect of cationic drugs on the transporting activity of human and rat OCT\/Oct 1\u20133 in vitro and implications for drug\u2013drug interactions","volume":"38","author":"Umehara","year":"2008","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.exer.2024.110098_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0039-6257(81)90145-4","article-title":"Clinical biochemistry of tears","volume":"26","author":"Van Haeringen","year":"1981","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2024.110098_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0039-6257(81)90145-4","article-title":"Clinical biochemistry of tears","volume":"26","author":"Van Haeringen","year":"1981","journal-title":"Surv. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2024.110098_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jop.2018.0106","article-title":"Ocular distribution of cyclosporine following topical administration of OTX-101 in New Zealand white rabbits","volume":"35","author":"Weiss","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.exer.2024.110098_bib52","first-page":"768","article-title":"Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations","volume":"289","author":"Yabuuchi","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"7","key":"10.1016\/j.exer.2024.110098_bib53","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1124\/dmd.108.021121","article-title":"Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition","volume":"36","author":"Zhang","year":"2008","journal-title":"Drug Metabol. Dispos."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524003208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524003208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T23:55:33Z","timestamp":1730332533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483524003208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":53,"alternative-id":["S0014483524003208"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2024.110098","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic cation transporter 1 in the lacrimal gland facilitates the entry of systemic drugs causing ocular surface toxicity","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2024.110098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110098"}}